Physician

Aaron Ciner, M.D.

According to 2025 Medicare claims, Aaron Ciner, M.D. (NPI: 1972917540) practices internal medicine in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Baltimore, MD. This provider's primary affiliated billing organization is UNIVERSITY OF MARYLAND ONCOLOGY ASSOCIATES, PA (NPI: 1679523575; TIN: 521949649) and primary practice location at 21201-1544.

Ciner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 106 traditional Medicare patients, billed 372 HCPCS/CPT codes, and received $36,313 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 355 prescription claims across 48 beneficiaries totaling $854,449 in drug costs, led by Imatinib Mesylate (Imatinib Mesylate). DME data shows 49 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $8,052 to $854,449. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	36	99	$11,520
2022	75	285	$29,302
2023	96	394	$43,204
2024	106	372	$36,313

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	18	82	$8,052
2016	43	375	$22,171
2017	19	134	$3,463
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$4,067
2021	12	74	$37,684
2022	27	191	$445,998
2023	41	284	$731,007
2024	48	355	$854,449

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	49	$1,590

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	24	24	$148
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	15	15	$140
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	41	169	$111
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	15	33	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	35	58	$68

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imatinib Mesylate	Imatinib Mesylate	11	330	$49,472
Zarxio	Filgrastim-Sndz	11	78	$26,309
Eliquis	Apixaban	15	618	$11,994
Dexamethasone	Dexamethasone	19	621	$739
Ondansetron Hcl	Ondansetron Hcl	42	840	$455

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	23	$1,195
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$245
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$150

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Aaron Ciner, M.D.?

Tedicare shows public-source Medicare data for Aaron Ciner, M.D. (NPI 1972917540), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Ciner, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aaron Ciner, M.D.?

Aaron Ciner, M.D. is linked to UNIVERSITY OF MARYLAND ONCOLOGY ASSOCIATES, PA (billing NPI 1679523575) in the available physician profile data.

Does Aaron Ciner, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.